CASE REPORT  
Niger J Paed 2013; 40 (2): 201 –203  
Oluwayemi IO  
Ade-Ojo IP  
Ajayi IA  
Myasthenia gravis following chicken  
pox infection in a Nigerian primary  
school girl  
DOI:http://dx.doi.org/10.4314/njp.v40i2,21  
Accepted: 12th November 2012  
Abstract We report a case of my-  
asthenia gravis occurring post  
drooping of both upper eye lids  
which worsens as the day pro-  
gresses and has persisted for more  
than one year. There was good  
response to Neostigmine.  
(
Oluwayemi IO  
Ade-Ojo IP, Ajayi IA  
)
Chicken pox infection in a 9 year  
old Nigerian girl. The girl was  
growing and seeing normally until 2  
weeks after a chicken pox infection  
when she observed progressive  
Departments of Paediatrics,  
Obstetrics, Gynaecology,  
Ophthalmology, Ekiti State University  
Teaching Hospital, Ado-Ekiti  
Introduction  
bilaterally. Other systems were essentially normal.  
Myasthenia gravis (MG) is an autoimmune neuromuscu-  
lar disorder resulting in fluctuating muscle weakness  
and fatigability. The weakness is caused by circulating  
A diagnosis of myasthenia gravis probably secondary to  
thymoma was made.  
1
antibodies that block acetylcholine receptors at the post-  
synaptic neuromuscular junction inhibiting the excita-  
tory effects of the neurotransmitter acetylcholin2 e on  
nicotinic receptors in neuromuscular junctions. The  
incidence of myasthenia gravis is 3-30 cases per million  
Investigations: Antibodies against Acetylcholine recep-  
tor was not detected; Full blood count showed relative  
lymphocytosis (PCV 44%, total WBC 5,300; Neutrophil  
24%. Lymphocytes 72%, Monocytes 4%); Erythrocyte  
sedimentation rate 11mm/hr; Electrolyte and urea within  
normal limit; Chest X-ray, no abnormality detected,  
Magnetic resonance imaging of the skull and Computed  
tomography of the chest revealed a normal study.  
She was given intravenous Neostigmine 0.05mg/kg  
(2.5mg) slowly with remarkable improvement: the two  
upper eyelids opened widely within 5 minutes of ad-  
ministration of Neostigmine. Thereafter she was placed  
on oral Neostigmine 7.5mg qds with sustained clinical  
improvement and patient continued to do well, able to  
see without lifting her chin upward. She was also re-  
viewed by an ophthalmologist .  
3
per year. Myasthenia gravis occurs in both genders and  
affects all races. All age groups can be affected but most  
commonly people from 50 to 70 years. In females inci-  
dence of MG peaks in the third decade o4f life, whereas it  
th  
th  
peaks in the 6 and 7 decades in males.  
Case Presentation  
A.M., a nine year old primary 6 girl presented with 13  
month history of variable drooping of both upper eye  
lids and double vision. She observed difficulty in lift-  
ing up both upper eye lids after engaging in some ac-  
tivities as the day progresses making it difficult for her  
to see clearly. She therefore had to lift her chin upward  
to allow her to see. She usually felt normal, able to see  
without difficulty, on waking up from sleep but be-  
comes weak and easily gets tired as the day progresses  
particularly when she engages in her daily activities.  
There was associated double vision and difficulty seeing  
distant objects. She had chicken pox two weeks be-  
fore onset of above symptoms. In addition she also  
complained of painful swallowing and chest pain.  
Before administration of  
Neostigmine.  
Examination revealed a young girl who was not small  
for age, not pale, afebrile, anicteric . Significant find-  
ings were on ocular examination . With manual eleva-  
tion of the eyelids visual acuity were normal with  
glasses. She had bilateral ptosis, ophthalmoplegia,  
pupils were 3mm equal bilaterally and reacting normally  
to light. Posterior ocular segments were normal  
After administration of  
Neostigmine  
2
02  
Discussion  
ciated with MG includes: female, and people with cer-  
tain human leucocyte antigen types (HLA-BB, HLA-  
DRw3, and HLA-DQw2). We could not do an HLA  
typing in this patient. MG is also associated with various  
autoimmune diseases like Hashimoto’s thyroiditis,  
Grave’s disease, rheumatoid arthritis, diabetes1,4mellitus  
type I, Lupus and demyelinating CNS diseases.  
1
,4  
Myasthenia gravis is idiopathic in most patients. In  
children, three types of myasthenic syndrome can be  
distinguished: 1. Neonatal: Pregnant mothers with my-  
1
asthenia gravis in 12% of cases pass the antibodies to  
the infant through the placenta, causing neonatal myas-  
thenia gravis. The symptoms will start in the first two  
days and disappear within a few weeks. 2. Congenital:  
this occurs very rarely in children of healthy mothers  
with symptoms beginning at birth. It is not caused by an  
autoimmune process but due to synaptic malformation,  
which in turn is caused by genetic mutations and the  
inheritance pattern is typically autosomal recessive. 3.  
Juvenile myasthenia gravis: it occurs in children but  
after the peripartum pe1riod. The hallmark of myasthenia  
gravis is fatiguability. In our patient eyelid muscle  
weakness was the first symptom noticed. This has been  
reported to be the case in most cases, while in a few  
others difficulty in swallowing and slurred speech may  
be the first presentation. The muscles become progres-  
sively weaker during periods of activity and improved  
after periods of rest. The muscles controlling movement  
of the eyeballs and eye lids, facial expressions, chewing,  
Diagnosis of myasthenia gravis can be difficult as the  
5
symptoms can be subtle. A thorough physical examina-  
tion can reveal easy fatigability, with the weakness im-  
provin,4g after rest and worsening again on repeat exer-  
1
cise. There was improvement in the symptoms of the  
above patient after rest. Our patient possibly fell in the  
group of patients with negative antibodies to acetylcho-  
line receptors much more so that her symptoms were  
predominantly ocular. In suspected cases serology can  
be performed to detect antibodies against the acetylcho-  
line receptor. This test has a sensitivity of 80-95% in  
generalized severe cases but may be negative in up to  
5
50% of ocular myasthenia gravis. Patients who are  
negative for anti-acetylcholine receptor antibodies may  
1
,4  
be seropositive for antibodies against MuSK protein.  
Electromyography considered to be the most sensitive  
1
5
talking, and swallowing are particularly susceptible.  
Often, physical examination yields normal finding. The  
degree of muscle involvement varies raging from local-  
ized form limited to the eye muscles (ocular myasthenia)  
to a generalized, severe form affecting many muscles,  
sometimes including respiratory muscles.  
test is not very specific for MG. Endrophonium test is  
5
limited to situation where oth,7er investigations do not  
4
yield a conclusive diagnosis. In this test intravenous  
endrophonium chloride or Neostigmine is administered;  
these drugs block the breakdown of acetylcholine by  
cholinesterase and temporarily increase the levels of  
acetylcholine at the neuromuscular junction thereby re-  
lieving weakness temporarily in ocular myasthenia gra-  
The patient reported above did not have respiratory mus-  
cle involvement but obviously seemed to have some  
weakness of other muscles because of the history of  
easy fatiguability after engaging in her daily activities.  
Symptoms varies including; asymmetrical ptosis, diplo-  
pia (due to weakness of muscle that control movement  
of the eyeballs), unstable/ waddling gait, weakness in  
arms, hands, fingers, legs, and neck, a change in facial  
expression, dysphagia, shortness of breath and dy-  
sarthria. The patient above did not have any thymus  
involvement even though it has been reported that up  
to 75% of myasthenia gravis patients have an,4abnormal-  
7
vis. A chest X-ray may identify widening of mediasti-  
num suggestive of thymoma, but CT or MRI are more  
sensitive ways to ide,n8tify thymomas which are closely  
4
associated with MG. MRI of the cranium and orbits is  
also performed to exclude compressive lesions of the  
4
cranial nerves and ocular muscles. All these tests were  
negative in the case reported.  
Treatment involves use of cholinest,e4rase inhibitors such  
1
as Neostigmine or Pyridostigmine. Corticosteroids are  
typically used in moderate or severe cases of MG that  
fail to respond adequately to acetylcholine inhibitors and  
1
ity of the thymus and 10% have a thymoma. In myas-  
4
thenic crisis there is paralysis of the respiratory muscles  
necessitating assisted ventilation to sustain life. Crisis is  
often triggered by infection, fever, adverse drug reaction  
or emotional stress in patients whose respiratory mus-  
cles are already weak. Cardiac muscle is generally not  
affected by MG since it is regulated by autonomic nerv-  
thymectomy. Thymectomy is the standard treatment for  
all patients with thymoma and for patients aged 10-  
1
,4,  
55years without thymoma but generalized MG. Im-  
munoglobulin is useful during myasthenia crisis in pa-  
tients with severe weakness poorly controlled with other  
agents. The effect is rapid1,4b,6ut transient and the same is  
The reported case re-  
6
1
ous system. Myasthenia gravis is an autoimmune chan-  
true for plasmapharesis.  
nelopathy featuring antibodies directed against the  
body’s own proteins. Our patient had a history of  
chicken pox two weeks before onset of myasthenic  
symptoms. The causative role of this preceding infec-  
tion cannot be proven. Although it has been proposed  
that sensitization to a foreign antigen which has cross  
reactivity with acetylcholine receptor could be a cause  
of MG but there is yet no known infective agent that  
sponded very well to Neostigmine tablets with relieve of  
symptoms.  
Conclusion  
we report this case of MG following chicken pox infec-  
tion in a nine year old Nigerian girl to serve as a tem-  
plate for further investigation into the yet unknown  
pathogen associated with MG.  
4
could account for this. Various drugs may also induce  
or exacerbate symptoms of MG4 which often resolve  
after discontinuation of the drugs. Other findings asso-  
2
03  
References  
1
.
Harvey BS. Disorders of Neuro-  
muscular transmission and of mo-  
tor neurons: myasthenia gravis. In:  
4. Goldenberg WD. Myasthenia gra-  
vis. e Medicine. http://  
emedicine.com/neuro/topic  
232.htm. Retrieved 27th July  
2012.  
5. Scherer K, Bedlack RS, Simel DL.  
Does this patient have myasthenia  
gravis? JAMA 2005; 293(15):1906  
-14.  
6. Bedlack RS, Sanders DB. How to  
handle myasthenic crisis. Essential  
steps in patient care. Postgrad  
Med 2000;107(4):211-4, 220-2.  
7. Seybold ME. The office tensilon  
test for ocular Myasthenia gravis.  
Ach Neurol 1986; 43(8):842-3  
8. De Kraker M, Kluin J, Renken N,  
Maat AP, Bogers AJ. CT and  
Myesthenia gravis: correlation  
between mediastinal imaging and  
histopathological findings. Interact  
Cardiovasc Thorac Surg. 2005;4  
(3):267-71  
Nelson textbook of Paediatrics,  
th  
1
2
8 ed. Philadelphia: Saunders,  
007: 2554-7.  
2
3
.
.
Conti-Fine BM, Milani M,  
Kaminski HJ. Myasthenia gravis:  
past, present and future. J Clin  
Invest 2006; 116(11):2843-51.  
McGrogan A, Sneddon S, deVries  
CS. The Incidence of myasthenia  
gravis: a systematic literature re-  
view. Neuroepidemiology 2010;  
3
4(3): 171-183.